Meet Heliocare Luminance, your daily inside-out support for brighter, more even-looking skin
Financial Considerations Before Starting Treatment Before beginning GLP-1 therapy, patients may wish to discuss financial planning with their healthcare provider
In November 2023, AstraZeneca and Eccogene signed an exclusive license agreement for ECC5004, an investigational oral once-daily GLP-1RA for treating obesity, type 2 diabetes, and other cardiometabolic conditions
This opened a regulatory door for federally licensed 503B compounding pharmacies to make products containing semaglutide or tirzepatide, the same active ingredients brand-name GLP-1 drugs
Post JYM provides the essential nutrients your body needs immediately after training to maximize recovery and results
Most patients tolerate semaglutide well once their bodies adapt